Erdon-100 TR Uses

Rating: 5 - 1 review(s)
How times a day do you take this medicine?
sponsored

What is Erdon-100 TR?

Erdon-100 TR is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and other symptoms of arthritis of the joints (eg, osteoarthritis), such as inflammation, swelling, stiffness, and joint pain. However, Erdon-100 TR does not cure osteoarthritis and will help you only as long as you continue to use it.

Erdon-100 TR topical 3% gel is also used to treat actinic keratosis, a skin problem that may become cancerous if not treated. The exact way that topical Erdon-100 TR helps this condition is unknown.

Erdon-100 TR topical solution is used to treat pain and swelling caused by osteoarthritis of the knees.

Erdon-100 TR topical patch is used to treat acute pain caused by minor strains, sprains, and contusions (bruises).

Erdon-100 TR is available only with your doctor's prescription.

Erdon-100 TR indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Intramuscular

Renal colic

Adult: As Erdon-100 TR Na: 75 mg, may repeat once after 30 min if needed. Max: 150 mg/day. Max period: 2 days.

Intramuscular

Bursitis, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis, Acute gout, Dysmenorrhoea

Adult: As Erdon-100 TR Na: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions. Max period: 2 days.

Intravenous

Postoperative pain

Adult: As Erdon-100 TR Na: 75 mg infusion in glucose 5% or NaCl 0.9% (previously buffered w/ Na bicarbonate) given over 30-120 min or as bolus inj, may repeat after 4-6 hr if necessary. Max period: 2 days.

Intravenous

Prophylaxis of postoperative pain

Adult: As Erdon-100 TR Na: Initially, 25-50 mg infusion given after surgery over 15-60 min followed by 5 mg/hr. Alternatively, initial dose may be given as bolus inj over 5-60 sec followed by additional inj, may repeat after 4-6 hr if necessary. Max: 150 mg/day. Max period: 2 days.

Ophthalmic

Postoperative ocular inflammation

Adult: As Erdon-100 TR Na (0.1% soln): Instill into the appropriate eye 4 times daily starting 24 hr after surgery for up to 28 days.

Ophthalmic

Inflammation and discomfort after strabismus surgery

Adult: As Erdon-100 TR Na (0.1% soln): Instill 1 drop 4 times daily for the 1st wk; then tid in the 2nd wk, bid in the 3rd wk, and as required for the 4th wk.

Ophthalmic

Pain and discomfort after radial keratotomy

Adult: As Erdon-100 TR Na (0.1% soln): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.

Ophthalmic

Pain after accidental trauma

Adult: As Erdon-100 TR Na (0.1% soln): Instill 1 drop 4 times daily for up to 2 days.

Ophthalmic

Control of inflammation after argon laser trabeculoplasty

Adult: As Erdon-100 TR Na (0.1% soln): Instill 1 drop 4 times during the 2 hr before procedure followed by 1 drop 4 times daily, up to 7 days after procedure.

Ophthalmic

Prophylaxis of intra-operative miosis

Adult: As Erdon-100 TR Na (0.1% soln): Instill into appropriate eye 4 times w/in 2 hr before surgery.

Ophthalmic

Post-photorefractive keratectomy pain

Adult: As Erdon-100 TR Na (0.1% soln): Instill into the affected eye twice, an hr before surgery, then 1 drop twice at 5-min intervals immediately after surgery, then every 2-5 hr while awake for up to 24 hr.

Ophthalmic

Seasonal allergic conjunctivitis

Adult: As Erdon-100 TR Na (0.1% soln): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.

Oral

Bursitis, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis, Acute gout, Dysmenorrhoea

Adult: As Erdon-100 TR Na: 75-150 mg/day in divided doses. Max: 150 mg/day.

Oral

Migraine

Adult: As Erdon-100 TR K: Initially, 50 mg taken at the 1st sign of an attack, an additional dose of 50 mg may be taken after 2 hr if symptoms persist. If needed, further doses of 50 mg may be taken 4-6 hrly. Max: 200 mg/day.

Rectal

Acute gout, Bursitis, Dysmenorrhoea, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis

Adult: As Erdon-100 TR Na: 100 mg once daily.

Topical/Cutaneous

Actinic keratoses

Adult: As Erdon-100 TR Na (3% gel): Apply bid for 60-90 days.

Topical/Cutaneous

Osteoarthritis

Adult: As Erdon-100 TR Na (1.6% soln): Apply in small amounts (20 or 40 drops) onto affected area 4 times daily. As Na: (1% gel): Apply to the affected area 4 times daily. Max: 32 g/day over the affected area.

Topical/Cutaneous

Local symptomatic relief of pain and inflammation

Adult: As Erdon-100 TR Na (1% gel): Apply onto affected area 3 or 4 times daily.

Transdermal

Acute pain

Adult: Sprains, strains, contusions: 1 patch bid.

How should I use Erdon-100 TR?

Use Erdon-100 TR solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Erdon-100 TR solution.

Uses of Erdon-100 TR in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Erdon-100 TR is used to relieve pain from various conditions. This form of Erdon-100 TR is used to treat migraine headaches. Erdon-100 TR is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.

This medication may also be used to treat gout attacks.

How to use Erdon-100 TR

Read the Medication Guide provided by your pharmacist before you start taking Erdon-100 TR and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

Take this medication by mouth as directed by your doctor. Empty the contents of one packet into a cup containing 1 to 2 ounces (30 to 60 milliliters) of water. Mix well and drink all of it right away. Do not mix with any liquid other than water. If stomach upset occurs while taking this medication, take it with food, milk, or an antacid. However, if you take this medication with a meal high in fat, it may not work as well.

There are different brands and forms of this medication available. Because different forms do not have the same effects at equal strengths, do not switch forms of Erdon-100 TR unless your doctor tells you to.

To reduce your risk of stomach bleeding and other side effects, take this medication at the lowest effective dose. Do not increase your dose or take it more often than prescribed.

Pain medications work best if they are used as the first signs of pain occur. If you wait until the pain has worsened, the medication may not work as well.

Tell your doctor if your condition persists or worsens.

Erdon-100 TR description

sponsored

The active substance is sodium-[o[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (= Erdon-100 TR sodium).

Each enteric tablet contains 25 mg or 50 mg of Erdon-100 TR sodium.

One prolonged-release tablet contains 100 mg of Erdon-100 TR sodium.

Excipients/Inactive Ingredients: Gastro-Resistant Tablet: Core for 25 mg and 50 mg: Cellulose microcrystalline; lactose monohydrate; magnesium stearate; maize starch; povidone; silica, colloidal anhydrous; sodium starch glycolate (type A).

Coating for 25 mg and 50 mg: Hypromellose; iron oxide yellow (E172); macrogoglycerol hydroxystearate; methacrylic acid-ethyl acrylate copolymer; macrogol 8000; talc; titanium dioxide (E171); simeticone; alpha-octadecyl-omega-hydroxy-polyglykolether; sorbic acid.

Coating for 50 mg: Iron oxide red (E172).

SR Tablet: Tablet Core: Cetyl alcohol; magnesium stearate; povidone; silica; colloidal anhydrous; sucrose.

Tablet Coating: Hypromellose; iron oxide red (E172); macrogol 8000; polysorbate 80; sucrose; talc; titanium dioxide (E171). Printing Ink: Carbon black, shellac, ammonium hydroxide, simethicone.

Injection: Each ampoule also contains the following excipients: Mannitol, sodium metabisulfite (E223), benzyl alcohol, propylene glycol, water for injection, sodium hydroxide.

Erdon-100 TR dosage

sponsored

Erdon-100 TR Dosage

Generic name: Erdon-100 TR 18mg

Dosage form: capsule

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

General Dosing Instructions

Carefully consider the potential benefits and risks of Erdon-100 TR and other treatment options before deciding to use Erdon-100 TR. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.

The effectiveness of Erdon-100 TR when taken with food has not been studied in clinical studies. Taking Erdon-100 TR with food may cause a reduction in effectiveness compared to taking Erdon-100 TR on an empty stomach.

Acute Pain

For management of mild to moderate acute pain, the dosage is 18 mg or 35 mg orally three times daily.

Osteoarthritis Pain

For management of osteoarthritis pain, the dosage is 35 mg orally three times daily.

Dosage Adjustments in Patients with Hepatic Impairment

Patients with hepatic disease may require reduced doses of Erdon-100 TR compared to patients with normal hepatic function. As with other Erdon-100 TR products, start treatment at the lowest dose. If efficacy is not achieved with the lowest dose, discontinue use.

Non-Interchangeability with Other Formulations of Erdon-100 TR

Erdon-100 TR capsules are not interchangeable with other formulations of oral Erdon-100 TR even if the milligram strength is the same. Erdon-100 TR capsules contain Erdon-100 TR free acid whereas other Erdon-100 TR products contain a salt of Erdon-100 TR, i.e., Erdon-100 TR potassium or sodium. A 35 mg dose of Erdon-100 TR is approximately equal to 37.6 mg of sodium Erdon-100 TR or 39.5 mg of potassium Erdon-100 TR. Therefore, do not substitute similar dosing strengths of other Erdon-100 TR products without taking this into consideration.

More about Erdon-100 TR (Erdon-100 TR)

Consumer resources

Professional resources

Related treatment guides

Erdon-100 TR interactions

See also:
What other drugs will affect Erdon-100 TR?

Aspirin: Concomitant administration of Erdon-100 TR and aspirin is not recommended because Erdon-100 TR is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels and AUC values.

Anticoagulants: While studies have not shown Erdon-100 TR to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs. Because prostaglandins play an important role in hemostasis and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including Erdon-100 TR and warfarin, requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.

Digoxin, Methotrexate, Cyclosporine: Erdon-100 TR, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs. Ingestion of Erdon-100 TR may increase serum concentrations of digoxin and methotrexate and increase cyclosporine's nephrotoxicity. Patients who begin taking Erdon-100 TR or who increase their Erdon-100 TR dose or any other NSAID while taking digoxin, methotrexate or cyclosporine may develop toxicity characteristics for these drugs. They should be observed closely, particularly if renal function is impaired. In the case of digoxin, serum levels should be monitored.

Lithium: Erdon-100 TR decreases lithium renal clearance and increases lithium plasma levels. In patients taking Erdon-100 TR and lithium concomitantly, lithium toxicity may develop.

Oral Hypoglycemics:

Erdon-100 TR does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents. There are rare reports, however, from marketing experiences, of changes in effects of insulin or oral hypoglycemic agents in the presence of Erdon-100 TR that necessitated changes in the doses of such agents. Both hypo- and hyperglycemic effects have been reported. A direct causal relationship has not been established, but physicians should consider the possibility that Erdon-100 TR may alter a diabetic patient's response to insulin or oral hypoglycemic agents.

Diuretics: Erdon-100 TR and other NSAIDs can inhibit the activity of diuretics. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels.

Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline or digitoxin did not significantly affect the peak levels and AUC values of Erdon-100 TR. Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of Erdon-100 TR therapy.

Erdon-100 TR side effects

See also:
What are the possible side effects of Erdon-100 TR?

Fluid Retention and Edema: Fluid retention and edema have been observed in some patients taking Erdon-100 TR. Therefore, as with other NSAIDs, Erdon-100 TR should be used with caution in patients with history of cardiac decompensation, hypertension or other conditions predisposing to fluid retention.

Hematological Effects: Anemia is sometimes seen in patients receiving Erdon-100 TR or other NSAIDs. This may be due to fluid retention, GI blood loss or an incompletely described effect upon erythropoiesis.

Renal Effects: As a class, NSAIDs have been associated with renal papillary necrosis and other abnormal renal pathology in long-term administration to animals. In patients treated with Erdon-100 TR, rare cases of interstitial nephritis and papillary necrosis have been reported. A second form of renal toxicity, generally associated with NSAIDs, is seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supported role in the maintenance of renal perfusion. In these patients, administration of an NSAID results in a dose-dependent decrease in prostaglandin synthesis and secondarily, in a reduction of renal blood flow, which may precipitate over the renal failure. Patients at greater risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and the elderly.

Porphyria: The use of Erdon-100 TR in patients with hepatic porphyria should be avoided.

Aseptic Meningitis: As with other NSAIDs, aseptic meningitis with fever and coma has been observed in rare occasions in patients on Erdon-100 TR therapy. Although it is probably more likely to occur in patients with systemic lupus erythematosus and related connective tissue diseases, it has been reported in patients who do not have an underlying chronic disease. If signs or symptoms of meningitis develop in a patient on Erdon-100 TR, the possibility of it being related to Erdon-100 TR should be considered.

There may be pain and occasionally tissue damage at the site of injection when given IM.

Erdon-100 TR contraindications

See also:
What is the most important information I should know about Erdon-100 TR?

Hypersensitivity to Erdon-100 TR sodium or to any of the excipients of Erdon-100 TR.

Active gastric or intestinal ulcer, bleeding or perforation.

Last trimester of pregnancy.

Hepatic, renal and severe cardiac failure.

Patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid and/or other drugs with prostaglandin-synthetase inhibitory activity.

Treatment of peri-operative pain in setting of coronary artery bypass graft (CABG) surgery.

The use of high dose Erdon-100 TR (150 mg/day) for >4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.

Established Cardiovascular Disease or Significant Cardiovascular Risk Factors: The use of high dose Erdon-100 TR (150mg/day) for >4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension. If Erdon-100 TR treatment is needed, patients with established cardiovascular disease, uncontrolled hypertension or significant cardiovascular risk factors (eg, hypertension, hyperlipidaemia, diabetes mellitus and smoking) should be treated only after careful consideration and at doses ≤100 mg daily if the treatment is for >4 weeks. As the cardiovascular risks of Erdon-100 TR may increase with dose and duration of exposure, Erdon-100 TR should always be prescribed at the lowest effective daily dose and for the shortest duration possible.

Renal Impairment: Erdon-100 TR is contraindicated in patients with renal failure. No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Erdon-100 TR to patients with mild to moderate renal impairment.

Hepatic Impairment: Erdon-100 TR is contraindicated in patients with hepatic failure. No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Erdon-100 TR to patients with mild to moderate hepatic impairment.



Active ingredient matches for Erdon-100 TR:

Diclofenac in Bangladesh, Hong Kong.


Unit description / dosage (Manufacturer)Price, USD
Erdon-100 TR 100 mg x 10 x 10's

List of Erdon-100 TR substitutes (brand and generic names):

Erdon gel 10 mg/1 g x 1 tube 20 g
ESGIPYRIN AQ 75 MG INJECTION 1 vial / 1 ML injection each (Abbott India Ltd)$ 0.29
Esgipyrin AQ 75mg Injection (Abbott India Ltd)$ 0.29
Esgipyrin DS 25mg/ml INJ / 5x3ml (Sarabhai piramal)$ 0.44
Injectable; Injection; Diclofenac Sodium 25 mg / ml (Sarabhai piramal)
ESGIPYRIN-AQ inj 75 mg x 1ml (AHPL)$ 0.29
Esgipyrin-DS 25mg/ml INJ / 3ml (AHPL)$ 0.12
25 mg x 1 mL x 3ml (AHPL)$ 0.12
ESGIPYRIN-DS inj 25 mg x 1 mL x 3ml (AHPL)$ 0.12
Capsule, Prolonged Release; Oral; Diclofenac Sodium 100 mg
Capsules, Prolonged Release; Oral; Diclofenac Sodium 100 mg
Eunac 100 mg x 1000's
Eurofenac 1 % x 25 g (Europharm)
Eurofenac 1 % x 50 g (Europharm)
Dragee; Oral; Diclofenac Sodium 100 mg (Eva Biotech)
Dragee; Oral; Diclofenac Sodium 50 mg (Eva Biotech)
Tablet, Film-Coated; Oral; Mebeverine Hydrochloride 135 mg (Eva Biotech)
100 mg x 10's (Eva Biotech)$ 0.43
Evadol 100mg INJ / 10 (Eva Biotech)$ 0.43
EVADOL inj 100 mg x 2ml (Eva Biotech)$ 0.43
Evagel Diclofenac sodium 1 %, Linseedoil 3 %, Menthol 5 %, Methylsalicylate 10 %. GEL / 30g (Eva Biotech)$ 0.94
30g (Eva Biotech)$ 0.94
EVAGEL topical gel 30g (Eva Biotech)$ 0.94
Everser-D Serratiopeptidase 15 mg, Diclofenac potassium 50 mg. TAB / 100 (Evershine)
100's (Evershine)
EVERSER-D tab 10's (Evershine)
Exaflam 25 mg x 5 x 10's (Guardian)$ 5.46
Exaflam 50 mg x 5 x 10's (Guardian)$ 8.99
EXFLAM Capsule/ Tablet / 50mg / 10 units (Mepro)$ 0.14
EXFLAM Injection / 25mg per ml / 3ml units (Mepro)$ 0.10
50 mg x 10's (Mepro)$ 0.14
20 mg x 1 mL x 3mlx20 (Mepro)$ 1.52
Exflam 50mg TAB / 10 (Mepro)$ 0.14
Exflam 25mg/ml INJ / 2x10x3ml (Mepro)$ 1.67
Gel; Topical; Diclofenac Diethylamine 1.16% (Mepro)
Injectable; Injection; Diclofenac Sodium 20 mg / ml (Mepro)
Tablets; Oral; Diclofenac Sodium 50 mg (Mepro)
Exflam 20mg x 1mL INJ / 3mlx20 (Mepro)$ 1.52

References

  1. DailyMed. "DICLOFENAC EPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "diclofenac". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "diclofenac". http://www.drugbank.ca/drugs/DB00586 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Erdon-100 TR are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Erdon-100 TR. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

1 consumer reported useful

Was the Erdon-100 TR drug useful in terms of decreasing the symptom or the disease?
According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
Users%
Useful1
100.0%


Consumer reported price estimates

No survey data has been collected yet


1 consumer reported time for results

To what extent do I have to use Erdon-100 TR before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Erdon-100 TR. To get the time effectiveness of using Erdon-100 TR drug by other patients, please click here.
Users%
1 week1
100.0%


1 consumer reported age

Users%
16-291
100.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 25 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved